Global Regulatory Harmonisation

Global regulatory harmonisation standardises pharmaceutical requirements across international jurisdictions facilitating efficient worldwide commercialisation. International Council for Harmonisation develops common technical requirements. Acceptance of studies conducted in harmonised jurisdictions reduces redundant testing. Common labelling standards facilitate prescriber understanding. Mutual recognition agreements streamline approval processes.

Regional variations persist requiring region-specific adaptation. Regulatory submissions leverage harmonised standards reducing documentation burden. Clinical trial design encompasses multiple jurisdiction requirements simultaneously. Post-approval modifications coordinate across jurisdictions. Ongoing harmonisation efforts expand common ground.